BEAM Q1 2019 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$9M

Operating Income

-$13M

Net Income

-$14M

EPS (Diluted)

$-0.39

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$28M

Stock-Based Comp.

$869,000

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$134M

Cash & Equivalents

-$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$9M	-$7M	-29.6%
Operating Income	-$13M	-$10M	-34.5%
Net Income	-$14M	-$10M	-34.3%